Malignant neoplasm of fallopian tube
ICD-10 C57.0 is a billable code used to indicate a diagnosis of malignant neoplasm of fallopian tube.
Malignant neoplasm of the fallopian tube is a rare gynecologic cancer that arises from the epithelial cells lining the fallopian tubes. It is often diagnosed at an advanced stage due to nonspecific symptoms such as abdominal pain, abnormal vaginal bleeding, or pelvic mass. The fallopian tubes are responsible for transporting eggs from the ovaries to the uterus, and malignancies in this area can lead to serious complications, including metastasis to adjacent organs. Diagnosis typically involves imaging studies, such as ultrasound or CT scans, and histopathological examination following surgical intervention. The staging of fallopian tube cancer is crucial for determining treatment options and prognosis, with the FIGO staging system commonly used. Elevated levels of CA-125, a tumor marker, may be observed in patients, although it is not specific to fallopian tube cancer. Treatment often involves a combination of surgery, chemotherapy, and in some cases, radiation therapy, depending on the stage and extent of the disease.
Detailed surgical reports, pathology findings, and staging information.
Diagnosis and management of fallopian tube cancer, staging evaluations, and treatment planning.
Ensure accurate documentation of tumor markers and imaging studies.
Clear imaging reports indicating findings related to the fallopian tubes.
Imaging for suspected malignancies and follow-up imaging post-treatment.
Accurate descriptions of imaging findings are crucial for coding.
Performed for staging and treatment of fallopian tube cancer.
Operative report detailing the procedure and findings.
Gynecologic oncology specialists should ensure comprehensive documentation.
Common symptoms include abdominal pain, abnormal vaginal bleeding, and pelvic mass. However, these symptoms can be nonspecific and may overlap with other conditions.
Diagnosis typically involves imaging studies, such as ultrasound or CT scans, followed by histopathological examination of tissue obtained through biopsy or surgical intervention.
CA-125 is a tumor marker that may be elevated in patients with fallopian tube cancer, although it is not specific to this condition. It is often used to monitor treatment response.
Treatment usually involves surgical intervention, such as salpingo-oophorectomy, followed by chemotherapy. Radiation therapy may be considered in certain cases.
